Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia

Medical and Pediatric Oncology

Volumn 34, Issue 4, 2000, Pages 284-286

  Schroeter, Thomas ^a,c   Lanvers, Claudia ^b   Herding, Heinz ^a   Suttorp, Meinolf ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Children; Oncology; Pseudotumor cerebri

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BRAIN PSEUDOTUMOR; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; PRIORITY JOURNAL; SCHOOL CHILD;

ANTINEOPLASTIC AGENTS; CHILD; DIPLOPIA; FEMALE; HEADACHE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PARALYSIS; PSEUDOTUMOR CEREBRI; TRETINOIN; TROCHLEAR NERVE DISEASES;

EID: 0034028801     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200004)34:4<284::AID-MPO16>3.0.CO;2-D     Document Type: Article

References (13)

1. De The H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alfa gene to a novel transcribed locus. Nature 1990;347: 558-561.
2. 2) in acute promyelocytic leukemia. Blood 1993;82:3560-3563.
3. Warrell RP, Frankel SR, Miller WH. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385-1393.
4. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
5. Frankel SR, Eardley A, Lauwers G, et al. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992; 117:292-296.
6. Vormoor J, Boos J, Stahnke K, et al. Therapy of childhood acute myelogenous leukemias. Ann Hematol 1996;73:11-24.
7. Mahmoud HH, Hurwitz CA, Roberts WM, et al. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet 1993;342: 1394-1395.
8. Maden M, Ong DE, Chytil F, et al. Retinoid-binding protein distribution in the developing mammalian nervous system. Development 1990;109:75-80.
9. Visani G, Manfroi S, Tosi P, et al. All-trans-retinoic acid and pseudotumor cerebri. Leuk Lymph 1996;23:437-442.
10. Lanvers C, Wagner A, Dübbers A, et al. Pharmacokinetics and metabolism of low-dose ATRA in children - first observations. In: Hiddemann W, editor. "Acute leukemias VII - experimental approaches and novel therapies." Berlin; Springer; 1998. p 565-569.
11. Soler D, Cox T, Bullock P, et al. Diagnosis and treatment of benign intracranial hypertension. Arch Dis Child 1998;78:89-94.
12. Adamson PC, Reaman G, Finklestein JZ, et al. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-α2a in pediatric patients with refractory cancer. J Clin Oncol 1997;15: 3330-3337.
13. Decaudin D, Adams D, Naccache P, et al. Maintained all-trans retinoic acid therapy in a patient with pseudotumor cerebri despite aggravated symptoms. Leuk Lymph 1997;27:373-374.